Artificial Intelligence has received extensive coverage and is being considered today as a critical solution in many aspects of our lives. We will discuss the role of AI In medicine and more specifically in radiology, and provide practical considerations from an industry point of view, which may not always be emphasized or applied in the research environment.
Fred S. Azar, PhD has 15 years of industry experience in healthcare innovation, product/strategic partnership management and business development, with cloud-based digital health technologies, clinical data intelligence, multimodality imaging, and surgery navigation. Fred worked for multinational corporations such as GE, Siemens & most recently Philips where he was leading healthcare strategic alliances. Fred Azar is currently a Principal in Offering Management at IBM Watson Health, responsible for identifying & commercializing novel, AI-based digital health solutions, including FDA-approved multimodality imaging-focused applications. Fred has 11 granted patents, and co-authored 45+ publications & a book on translational multimodality medical imaging. Fred Azar has a PhD in BioEngineering from the University of Pennsylvania, and an MBA from the Wharton School of Business.